Study of severe pneumococcal infections in children
Part of Infections clinical trials.
This study tracks cases of invasive pneumococcal disease (a serious infection) in children and newborns. It may help clinicians better understand how these infections happen and guide future prevention and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a lab test showing pneumococcal bacteria in a normally sterile body fluid
- This could include blood, lung fluid (pleural fluid), joint fluid, spinal fluid (cerebrospinal fluid), or another sterile site
- A positive pneumococcal test from blood PCR (a DNA test) can also count
- The pneumococcal strain must be sent to the official national reference center or regional observatory
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls children and newborns with suspected or confirmed bacterial meningitis. The goal is to understand and improve care for serious infections that affect the lining around the brain.
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
This study looks at how long the bacteria that can cause pneumonia and ear infections stay in a child's nose and throat. It may help researchers understand how these germs spread and how to prevent infections in the future.
This study tests a new vaccine to protect infants from pneumococcal disease (a serious bacterial infection). Researchers want to see how well the vaccine works and how safe it is in healthy babies aged 2–6 months.
This study tests whether giving the pneumococcal vaccine during hospitalization for severe malnutrition can help prevent infections. It may help protect your child from serious illness.
This study collects laboratory samples from patients with invasive pneumococcal infections to learn about the germ and where it spreads. It may help doctors and public health teams track infection patterns and improve prevention and treatment planning.
Hear when a new Pneumococcal Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.